Table 3.

Outcome characteristics

Outcome variables	Case (n = 45)	Control (n = 45)	p value
Months from diagnosis to surgery, median (Q1–Q3)	8.6 (3.4–20.1)	1.3 (0.7–4.1)	< 0.001
ASA score			0.76
1, n (%)	22 (48.9)	19 (42.2)
2, n (%)	17 (37.8)	21 (46.7)
3, n (%)	6 (13.3)	5 (11.1)
Complications within 30 days, total n (%)	16 (35.6)	11 (24.4)	< 0.001
Postoperative hematoma, n (%)	3 (6.7)	2 (4.4)	1.0
Infection*, n (%)	3 (6.7)	6 (13.3)	0.49
Seizure, n (%)	3 (6.7)	0 (0)	0.24
New/worsened focal deficit, n (%)	4 (8.9)	3 (6.7)	1.0
Significant edema, n (%)	1 (2.2)	0 (0)	1.0
Other, n (%)	2 (4.4)	0 (0)	0.49
Age > 70 and complication, n (% of total patients aged > 70)	3/8 (37.5)	1/8 (12.5)	< 0.001
Days from surgery to complication, median (Q1–Q3)	2 (0–4)	15 (0–20)	0.24
Reoperation due to complication, n (%)	3 (6.7)	7 (15.6)	0.32
Postoperative rehabilitation, n (%)	8 (18.6)	7 (16.3)	1.0
Course of disease > 1 year			0.11
Recurrence, n (%)	4 (9.5)	0 (0)
Progress of remnant, n (%)	2 (4.8)	5 (11.4)
Stable disease, n (%)	27 (60.0)	34 (75.6)
Missing, n (%)	12 (26.7)	6 (13.3)
Adjuvant therapy, n (%)	2 (4.4)	2 (4.4)	1.0
Missing, n (%)	1 (2.2)	0 (0)
Reoperation of tumor, n (%)	3 (6.7)	4 (8.9)	0.21
Follow-up > 1 year
Focal deficit, n (%)	4 (8.9)	7 (15.6)	0.63
Epilepsy/AED, n (%)	3 (7.7)	14 (32.6)	< 0.01
Missing, n (%)	6 (13.3)	2 (4.4)
Postoperative work status			0.74
Pension, n (%)	13 (28.9)	13 (28.9)
Sick leave, n (%)	2 (4.4)	4 (8.9)
Partial sick leave, n (%)	3 (6.6)	5 (11.1)
Working full hours, n (%)	16 (35.6)	13 (28.9)
Other, n (%)	1 (2.2)	2 (4.4)
Missing, n (%)	10 (22.2)	7 (15.6)
Death before end of follow-up, n (%)	2 (4.4)	3 (6.7)	1.0

*Infections such as local wound infection, pneumonia, and urinary tract infection